Article info

Download PDFPDF

Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration in routine clinical practice in France: results from the RAINBOW study

Authors

  1. Correspondence to Professor Michel Weber; weber.michel{at}bbox.fr
View Full Text

Citation

Weber M, Kodjikian L, Coscas F, et al
Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration in routine clinical practice in France: results from the RAINBOW study

Publication history

  • Received August 9, 2019
  • Revised January 28, 2020
  • Accepted February 13, 2020
  • First published April 6, 2020.
Online issue publication 
April 06, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.